The Successful Implantation of Continuous-Flow Left Ventricular Assist Device as a Destination Therapy in Korea: Echocardiographic Assessment.
10.3346/jkms.2014.29.1.137
- Author:
Ga Yeon LEE
1
;
Sung Ji PARK
;
Sujin KIM
;
Namgyung CHOI
;
Dong Seop JEONG
;
Eun Seok JEON
;
Young Tak LEE
Author Information
1. Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Publication Type:Case Reports
- Keywords:
Heart Failure;
Mechanical Circulatory Support;
Heart-Assist Device;
HeartMate II
- MeSH:
Aged;
Dyspnea;
Echocardiography;
Heart Failure/*surgery;
*Heart-Assist Devices;
Humans;
Male;
Prosthesis Implantation;
Quality of Life;
Republic of Korea;
Treatment Outcome;
Ventricular Dysfunction, Left/*surgery
- From:Journal of Korean Medical Science
2014;29(1):137-140
- CountryRepublic of Korea
- Language:English
-
Abstract:
Left ventricular assist device (LVAD) is a good treatment option for the patients ineligible for cardiac transplantation. Several studies have demonstrated that a ventricular assist device improves the quality of life and prognosis of the patients with end-stage heart failure. A 75-yr-old man debilitated with New York Heart Association (NYHA) functional class III-IV due to severe left ventricular systolic dysfunction received LVAD implantation as a destination therapy. The patient was discharged with improved functional status (NYHA functional class II) after appropriate cardiac rehabilitation and education about how to manage the device and potential emergency situations. This is the first case of successful continuous-flow LVAD implantation as a destination therapy in Korea.
